NCT02430259View on ClinicalTrials.gov

Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention

PHASE3CompletedINTERVENTIONAL
Enrollment

566

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
SilicosisTuberculosis
Interventions
DRUG

Weekly INH / RRT given by DOT

weekly oral Rifapentine 15 mg/kg (up to 900mg) plus Isoniazid 15 mg/kg (up to 900mg) for 12 doses

Trial Locations (1)

317500

Wenling No.1 People's Hospital, Zhejiang, Taizhou

All Listed Sponsors
lead

Huashan Hospital

OTHER

NCT02430259 - Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention | Biotech Hunter | Biotech Hunter